Literature DB >> 9566701

Genetic alterations are frequent in APC but rare in the TGF-beta type II receptor gene in cancer in adenomas of the colon.

Y Akiyama1, O K Yagi, T Ishikawa, H Nagasaki, K Saitoh, Y Yuasa.   

Abstract

Cancer in adenomas are thought to be an excellent model of colorectal carcinogenesis based on the adenoma-carcinoma sequence. We searched for alterations in the APC mutation cluster region, the whole coding regions of TGF-beta type II receptor (RII) and beta-catenin exon 3 in 16 cases of cancer in adenomas of the colon. Overexpression of the p53 protein was also analyzed. Nine of the 16 cases showed APC mutations in both the adenoma and cancer regions. Loss of heterozygosity in APC was found in one cancer in adenoma that had no mutation. p53 overexpression was detected in one adenoma and 10 cancerous regions, most of which also exhibited APC alterations. Two cases showed a missense mutation at codon 191 or loss of heterozygosity in TGF-beta RII in both the adenoma and cancer. Our data support the hypothesis that alterations of APC and p53 are responsible for most of the adenoma-carcinoma pathway, rather than TGF-beta RII alterations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566701     DOI: 10.1016/s0304-3835(97)00490-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Mutations in TGFbeta-RII and BAX mediate tumor progression in the later stages of colorectal cancer with microsatellite instability.

Authors:  Masakazu Yashiro; Kosei Hirakawa; C Richard Boland
Journal:  BMC Cancer       Date:  2010-06-18       Impact factor: 4.430

2.  Frequent allelic imbalance on chromosome 18q21 in early superficial colorectal cancers.

Authors:  Y Akiyama; T Arai; H Nagasaki; O K Yagi; A Nakahata; T Nakajima; Y Ohkura; T Iwai; K Saitoh; Y Yuasa
Journal:  Jpn J Cancer Res       Date:  1999-12

3.  Detection of up to 65% of Precancerous Lesions of the Human Colon and Rectum by Mutation Analysis of APC, K-Ras, B-Raf and CTNNB1.

Authors:  Mandy Schneider; Bettina Scholtka; Uwe Gottschalk; Siegbert Faiss; Daniela Schatz; Kornelia Berghof-Jäger; Pablo Steinberg
Journal:  Cancers (Basel)       Date:  2010-12-29       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.